BlueLinx Holdings Inc. short interest in 2018
In 2018, BlueLinx Holdings Inc.'s disclosed short interest ran from 0.61% of shares outstanding on 31 Jan 2018 to 19.50% on 31 Dec 2018, a change of +18.89 percentage points. The year's high was 19.50% on 31 Dec 2018 and its low 0.54% on 28 Feb 2018, averaging 8.99% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.53 days on 30 Nov 2018. Full history: BlueLinx Holdings Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 0.61% (31 Jan 2018)
- End of year
- 19.50% (31 Dec 2018)
- Change
- +18.89 pp
- High
- 19.50% (31 Dec 2018)
- Low
- 0.54% (28 Feb 2018)
- Average
- 8.99%
- Highest days to cover
- 11.53 (30 Nov 2018)
- SEC filings marked
- 7
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Jan 2018 | 0.61% | 1.00 | |
| 15 Feb 2018 | 0.69% | 1.00 | |
| 28 Feb 2018 | 0.54% | 1.00 | |
| 15 Mar 2018 | 3.20% | 1.00 | 10-K filed, results (8-K) |
| 29 Mar 2018 | 2.98% | 1.00 | |
| 13 Apr 2018 | 4.55% | 1.86 | |
| 30 Apr 2018 | 3.92% | 2.08 | |
| 15 May 2018 | 3.13% | 1.54 | 10-Q filed, results (8-K) |
| 31 May 2018 | 2.84% | 2.02 | |
| 15 Jun 2018 | 3.25% | 1.88 | |
| 15 Aug 2018 | 9.56% | 3.12 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 11.66% | 8.17 | |
| 14 Sep 2018 | 11.38% | 5.18 | |
| 28 Sep 2018 | 12.65% | 5.24 | |
| 15 Oct 2018 | 16.53% | 4.20 | |
| 31 Oct 2018 | 17.52% | 5.37 | |
| 15 Nov 2018 | 17.21% | 5.15 | 10-Q filed |
| 30 Nov 2018 | 18.77% | 11.53 | |
| 14 Dec 2018 | 19.25% | 8.29 | |
| 31 Dec 2018 | 19.50% | 7.36 |
See also: BlueLinx Holdings Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.